Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript Inv. presentation Director departure Appointed director
|
WINDTREE THERAPEUTICS INC (WINT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/25/2023 |
4
| Williams Leslie J. (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 2,033 shares
@ $0 Granted 3,050 options to buy
@ $1.21, valued at
$3.7k
|
|
08/25/2023 |
4
| Strobeck Mark (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 2,300 shares
@ $0 Granted 3,450 options to buy
@ $1.21, valued at
$4.2k
|
|
08/25/2023 |
4
| SCOTT ROBERT A (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 2,033 shares
@ $0 Granted 3,050 options to buy
@ $1.21, valued at
$3.7k
|
|
08/25/2023 |
4
| Simonson Steven (SVP, Chief Medical Officer) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 15,867 shares
@ $0 Granted 23,800 options to buy
@ $1.21, valued at
$28.8k
|
|
08/25/2023 |
4
| Curtis Eric (SVP & COO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 14,667 shares
@ $0 Granted 22,000 options to buy
@ $1.21, valued at
$26.6k
|
|
08/25/2023 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 45,867 shares
@ $0 Granted 68,800 options to buy
@ $1.21, valued at
$83.2k
|
|
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2023 |
4
| Simonson Steven (SVP, Chief Medical Officer) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Paid exercise price by delivering 100 shares
@ $0 |
|
03/02/2023 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Paid exercise price by delivering 334 shares
@ $0 |
|
03/02/2023 |
4
| Curtis Eric (SVP & COO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Paid exercise price by delivering 99 shares
@ $0 |
|
03/02/2023 |
4
| CARMAN DIANE (SVP & General Counsel) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Paid exercise price by delivering 99 shares
@ $0 |
|
02/23/2023 |
4
| Huang James (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Disposed/sold 275,862 options to buy
@ $7.975, valued at
$2.2M
Disposed/sold 275,938 options to buy
@ $12.09, valued at
$3.3M
Disposed/sold 498,008 options to buy
@ $12.15, valued at
$6.1M
Disposed/sold 62,500 options to buy
@ $12, valued at
$750k
Granted 1,112,308 options to buy
@ $0.1411, valued at
$156.9k
Exercised (in-or-at-the-money) 1,112,308 options to buy
@ $0.1411, valued at
$156.9k
Granted 2,224,616 options to buy
@ $0.2152, valued at
$478.7k
|
|
07/27/2022 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 2,500 shares
@ $0.3799, valued at
$949.8 |
|
07/26/2022 |
4
| Hamill John P. (SVP & CFO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 3,000 shares
@ $0.3666, valued at
$1.1k
|
|
07/26/2022 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 2,500 shares
@ $0.374, valued at
$935 |
|
07/05/2022 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 4,500 shares
@ $0.4279, valued at
$1.9k
|
|
06/30/2022 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 7,000 shares
@ $0.4154, valued at
$2.9k
|
|
06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2022 |
4
| SCOTT ROBERT A (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 5,000 shares
@ $0 Granted 7,500 options to buy
@ $0.47, valued at
$3.5k
|
|
06/09/2022 |
4
| Huang James (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 5,000 shares
@ $0 Granted 7,500 options to buy
@ $0.47, valued at
$3.5k
|
|
06/09/2022 |
4
| Geffken Daniel E. (Director) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 5,000 shares
@ $0 Granted 7,500 options to buy
@ $0.47, valued at
$3.5k
|
|
03/17/2022 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 2,000 shares
@ $0.9799, valued at
$2k
|
|
03/15/2022 |
4
| Simonson Steven (SVP, Chief Medical Officer) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 5,000 shares
@ $0.9998, valued at
$5k
|
|
03/15/2022 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 3,000 shares
@ $0.9801, valued at
$2.9k
|
|
03/07/2022 |
4
| Simonson Steven (SVP, Chief Medical Officer) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 66,300 shares
@ $0 Granted 99,600 options to buy
@ $1.02, valued at
$101.6k
|
|
03/07/2022 |
4
| Hamill John P. (SVP & CFO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 66,300 shares
@ $0 Granted 99,600 options to buy
@ $1.02, valued at
$101.6k
|
|
03/07/2022 |
4
| Fraser Craig (President and CEO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 166,900 shares
@ $0 Granted 250,400 options to buy
@ $1.02, valued at
$255.4k
|
|
03/07/2022 |
4
| Curtis Eric (SVP & COO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 66,300 shares
@ $0 Granted 99,600 options to buy
@ $1.02, valued at
$101.6k
|
|
03/07/2022 |
4
| CARMAN DIANE (SVP & General Counsel) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 66,300 shares
@ $0 Granted 99,600 options to buy
@ $1.02, valued at
$101.6k
|
|
01/10/2022 |
4
| Center Laboratories, Inc. (10% Owner) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Disposed of 3,551,750 shares
@ $0 Bought 55,172 shares
@ $7.25, valued at
$400k
Bought 1,239,088 shares
@ $1.6, valued at
$2M
Disposed of options to buy
@ $3.68, valued at
$0 Disposed of 249,004 options to buy
@ $12.15, valued at
$3M
Bought 55,172 options to buy
@ $7.795, valued at
$430.1k
|
|
01/10/2022 |
4
| Bioengine Capital Inc. (10% Owner) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Disposed of 3,551,750 shares
@ $0 Bought 55,172 shares
@ $7.25, valued at
$400k
Sold 1,239,088 shares
@ $1.6, valued at
$2M
Disposed of options to buy
@ $3.68, valued at
$0 Disposed of 249,004 options to buy
@ $12.15, valued at
$3M
Bought 55,172 options to buy
@ $7.975, valued at
$440k
|
|
|
|
|